About
Inaedis develops scalable biopharmaceutical technologies that convert liquid biologics into room-temperature-stable powder and suspension formulations, enabling diverse and flexible drug delivery routes including inhaled, intranasal, and subcutaneous administration.
Explore Inaedis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.